Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0959-8049(01)00294-5PMID 11677105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study.

  2000cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Polychemotherapy for early breast cancer.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.

  1996cited by this paper
• The CONSORT Statement

  1996cited by this paper
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

  1996cited by this paper
• Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and

  1996cited by this paper
• Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

  1995cited by this paper
• Randomized cooperative study of perioperative chemotherapy in breast cancer.

  1995cited by this paper
• Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.

  1994cited by this paper
• Perioperative adjuvant chemotherapy in breast cancer. The Scandinavian Adjuvant Chemotherapy Study 1.

  1989cited by this paper
• Presence of a growth-stimulating factor in serum following primary tumor removal in mice.

  1989cited by this paper
• Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.

  1989cited by this paper
• Is there a role for perioperative adjuvant therapy in the treatment of early breast cancer?

  1988cited by this paper
• Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.

  1988cited by this paper
• Treatment of node-negative breast cancer patients with short course of chemotherapy immediately after surgery.

  1986cited by this paper
• The genetic origin of drug resistance in neoplasms: implications for systemic therapy.

  1984cited by this paper
• Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

  1983cited by this paper
• Effect of surgical removal on the growth and kinetics of residual tumor.

  1979cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• Surgical adjuvant chemotherapy. Results with one short course with cyclophosphamide after mastectomy for breast cancer

  1978cited by this paper
• Surgical adjuvant chemotherapy.

  1977cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer

  2025cites this paper
• Impact of sample size, sojourn time distribution on the performance of multistate semi-Markov model for analyzing disease progression: a simulation study

  2025cites this paper
• Nonparametric estimation of a future entry time distribution given the knowledge of a past state occupation in a progressive multistate model with current status data

  2024cites this paper
• Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer

  2024cites this paper
• Cryo-assisted resection of primary breast cancer en bloc and tumor cryoablation connected with local drug delivery and targeting of tumor fluids. Experimental and clinical studies

  2023cites this paper
• Protection against Spread of Cancer in Breast Cancer and Melanoma using Aqueous Zinc Chloride to Kill Residual Malignant Tissue at the Time of Surgery

  2023cites this paper
• Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment

  2021cites this paper
• TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients

  2021cites this paper
• Dogs undergoing surgical excision of mast cell tumors are not at increased risk of incisional complications.

  2021cites this paper
• A tutorial on frailty models

  2020cites this paper
• Nonparametric analysis of nonhomogeneous multistate processes with clustered observations

  2020cites this paper
• Anti-inflammatory catecholic chitosan hydrogel for rapid surgical trauma healing and subsequent prevention of tumor recurrence

  2020cites this paper
• Nonparametric tests for transition probabilities in nonhomogeneous Markov processes

  2019influential citation
• Intraoperative Cryosurgical Freezing Assists with Local Drug Delivery and Targeting of Tumor Fluids in VX2 Model, which Translates in Locoregional Drug Targeting of Tumor Fluids during Cryoprobe-Assisted Surgical Resection of Breast Cancer

  2019cites this paper
• Nonparametric analysis of nonhomogeneous multi-state processes based on clustered observations

  2019cites this paper
• Alter als unabhängiger prognostischer Faktor für das Überleben von Krebspatienten

  2018influential citation
• Investigating hospital heterogeneity with a competing risks frailty model

  2018cites this paper
• Non-parametric estimation of transition probabilities in non-Markov multi-state models: The landmark Aalen–Johansen estimator

  2018cites this paper
• Potential impact of invasive surgical procedures on primary tumor growth and metastasis

  2018cites this paper
• Explorer The EORTC Breast Cancer Group : major achievements of 50 years of research and future directions

  2017cites this paper
• Timing of Breast Cancer Surgery—How Much Does It Matter?

  2017cites this paper
• Surgery for Cancer: A Trigger for Metastases.

  2017cites this paper
• Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes.

  2016cites this paper
• Radiotherapy Induces Development of Fragmented QRS in Patients with Breast Cancer

  2015cites this paper
• Frailties in multi-state models: Are they identifiable? Do we need them?

  2015cites this paper
• Adjusting for centre heterogeneity in multicentre clinical trials with a time‒to‒event outcome

  2014cites this paper
• Dynamic aspects of competing risks with application to medical data

  2014cites this paper
• Estimation for Non-Markov Multi-states Models

  2014cites this paper
• The EORTC Breast Cancer Group: major achievements of 50 years of research and future directions

  2012cites this paper
• Optimal timing of adjuvant treatment in patients with early breast cancer

  2011cites this paper
• Thesis Mieog.indb

  2011cites this paper
• Breast cancer spatial heterogeneity in near-infrared spectra and the prediction of neoadjuvant chemotherapy response.

  2011cites this paper
• Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials

  2011cites this paper
• efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

  2011cites this paper
• Prognostic factors for local recurrence following breast-conserving treatment in young women

  2010cites this paper
• Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy.

  2010cites this paper
• Revisiting perioperative chemotherapy: the critical importance of targeting residual cancer prior to wound healing

  2009cites this paper
• Focus On Perioperative therapy in HER2 1 patients

  2009cites this paper
• The Perioperative Period is an Underutilized Window of Therapeutic Opportunity in Patients With Colorectal Cancer

  2009cites this paper
• Timing of adjuvant therapy.

  2009cites this paper
• The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model

  2009cites this paper
• Perioperative therapy in HER2+ patients

  2009cites this paper
• Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer

  2008cites this paper
• Baseline and treatment effect heterogeneity for survival times between centers using a random effects accelerated failure time model with flexible error distribution

  2007cites this paper
• Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

  2007cites this paper
• Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.

  2007influential citation
• The Immunomodulatory Effects of Laparoscopic Surgery

  2007cites this paper
• University of Groningen Estimation and prediction in a multi-state model for breast cancer Putter,

  2006cites this paper
• Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?

  2006cites this paper
• Influence of Timing of Initiation of Adjuvant Chemotherapy Over Survival in Breast Cancer: A Negative Outcome Study by the Spanish Breast Cancer Research Group (GEICAM)

  2006cites this paper
• Estimation and Prediction in a Multi‐State Model for Breast Cancer

  2006cites this paper
• Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial

  2006cites this paper
• Cancer surgery: risks and opportunities

  2006cites this paper
• Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.

  2006cites this paper
• Reduced rank proportional hazards model for competing risks.

  2006cites this paper
• Isolated loco-regional recurrence of breast cancer is m ore com m on in young patients and follow ing breast conserving th erapy: Long-term results of European O rganization for Research and Treatm ent of C ancer studies

  2006cites this paper
• Impact of locoregional treatment on th e early-stage breast cancer patients : a retrospective analysis

  2006cites this paper
• Impact of established prognostic factors in early stage breast cancer in very you ng breast cancer patients; a translational research project u sing pooled datasets derived from 4 EO RT C Breast G rou p Trials

  2006cites this paper
• Overexpression of P70 S6 kinase protein is associated w ith increased risk of locoregional recu rrence in nod e-negative prem enopau sal early b reast cancer patients

  2006cites this paper
• Postoperative Strahlentherapie beim invasiven Mammakarzinom

  2005cites this paper
• Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.

  2005cites this paper
• Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

  2005cites this paper
• Efficacy of adjuvant chemotherapy according to hormone receptor status in young breast cancer patients

  2004cites this paper
• Séquence des traitements adjuvants après chirurgie du cancer du sein

  2004cites this paper
• [Sequencing of adjuvant treatment after surgery for invasive breast cancer].

  2004cites this paper
• Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.

  2004cites this paper
• Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients

  2004cites this paper
• Cáncer de mama T1NOMO: ¿existe un rol para quimioterapia?

  2004cites this paper
• Does timing of adjuvant chemotherapy for early breast cancer influence survival?

  2003cites this paper
• Excisional surgery for cancer cure: therapy at a cost.

  2003cites this paper
• Randomized Multicentric Study of Perioperative Chemotherapy With Mitoxantrone in Early Breast Cancer

  2003cites this paper
• Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.

  2003cites this paper
• Women's health literaturewatch.

  2002cites this paper
• Perioperative chemotherapy in patients with node-negative postmenopausal breast cancer.

  2002cites this paper
• The EORTC Breast Cancer Group: 40 years of research contributing to improve breast cancer management.

  2002cites this paper
• Women's Health LiteratureWatch

  2002cites this paper
• Dogs undergoing surgical excision of mast cell tumors are not at increased risk of incisional complications

  year unknowncites this paper
• Dogs undergoing surgical excision of mast cell tumors are not at increased risk of incisional complications

  year unknowncites this paper
• Dogs undergoing surgical excision of mast cell tumors are not at increased risk of incisional complications

  year unknowncites this paper